Parallel Advisors’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-68,524
Closed -$500K 3536
2022
Q4
$500K Sell
68,524
-5,544
-7% -$39.1K 0.02% 417
2022
Q3
$513K Hold
74,068
0.02% 383
2022
Q2
$518K Hold
74,068
0.02% 383
2022
Q1
$604K Buy
+74,068
New +$668K 0.02% 379

Other funds holding AMYT

Parallel Advisors's AMYT Position: Q1 2023 in Review

Parallel Advisors sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 68,524 shares — an estimated $500K sold.

Parallel Advisors first reported a position in AMYT in Q1 2022 and held it in 4 quarters. The position peaked at $604K in Q1 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Parallel Advisors reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Parallel Advisors sold 68,524 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $500K.
  • Parallel Advisors first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2022 and held it in 4 quarters.
  • Parallel Advisors's Amryt Pharma plc American Depositary Shares position peaked at $604K in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.